Honjyo, Japan

Kazuyasu Asami



 

Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Saitama, JP (2005)
  • Honjyo, JP (2013 - 2015)

Company Filing History:


Years Active: 2005-2015

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Kazuyasu Asami: Innovator in Aminothiazole Derivatives

Introduction

Kazuyasu Asami is a prominent inventor based in Honjyo, Japan, known for his contributions to pharmaceutical innovations. With a total of five patents to his name, he has made significant advancements in the production of aminothiazole derivatives, showcasing his expertise in selective demethylation processes.

Latest Patents

Among Kazuyasu Asami's latest patents is a method for producing aminothiazole derivatives and their production intermediates. This innovative method involves the selective demethylation of a 2-methoxy group, leading to the effective production of compounds represented by specific formulas. This technique not only enhances the efficiency of chemical reactions but also contributes to the development of various therapeutic agents.

Career Highlights

Kazuyasu has built a successful career at Zeria Pharmaceutical Co., Ltd., a company dedicated to advancing pharmaceutical research and development. His work plays a crucial role in the company's innovations and product offerings, reinforcing his position as a key figure in the field.

Collaborations

Throughout his career, Kazuyasu has collaborated with notable coworkers such as Masaaki Nagasawa and Ryu Nakao. Their collective expertise and teamwork have contributed to the successful development of patented methodologies in their research endeavors.

Conclusion

Kazuyasu Asami's innovative work in the field of aminothiazole derivatives exemplifies the vital role of inventors in advancing pharmaceutical science. His patents not only highlight his creative approach but also pave the way for future developments in medicinal chemistry, making significant impacts on healthcare and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…